🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer...
Status
Not Yet Recruiting
Location
London Health Sciences Center
Start Date
2026-02
Trial ID
NCT07292142
Treatments Being Tested
In this study, patients with locally advanced or metastatic NSCLC after fir...
Status
Unknown
Location
Zhongshan Hospital, Fudan University
Start Date
2021-09-01
Trial ID
NCT05008861
This research protocol outlines an exploratory study on the combination of ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07486492
Treatments Being Tested
the investigators plan to initiate a prospective, multicenter, randomized, ...
Status
Recruiting
Location
Changzhou No.2 People's Hospital
Start Date
2024-06-01
Trial ID
NCT06405113
Treatments Being Tested
Immunotherapy has recently become a main-stream treatment option in cancer ...
Status
Recruiting
Location
Soroka Medical Center
Start Date
2023-09-01
Trial ID
NCT05502913
Treatments Being Tested
The gut microbiota can modulate the effectiveness of cancer therapies, espe...
Status
Completed
Location
Hospital Universitario Ramón y Cajal
Start Date
2021-04-23
Trial ID
NCT04924374
Treatments Being Tested
The standard treatment for locally advanced rectal cancer is neoadjuvant ch...
Status
Enrolling By Invitation
Location
First Affiliated Hospital of Ningbo University
Start Date
2025-03-01
Trial ID
NCT06931808
To find out if adding treatment with fecal microbiota transplantation (FMT)...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-02-19
Trial ID
NCT06218602
Treatments Being Tested
This study plans to reconstruct intestinal microecology through fecal micro...
Status
Recruiting
Location
Changzhou No.2 Poeple's Hospital
Start Date
2024-06-01
Trial ID
NCT06403111
Treatments Being Tested